Product NDC: | 68012-258 |
Proprietary Name: | CYCLOSET |
Non Proprietary Name: | bromocriptine mesylate |
Active Ingredient(s): | .8 mg/1 & nbsp; bromocriptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68012-258 |
Labeler Name: | Santarus, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020866 |
Marketing Category: | NDA |
Start Marketing Date: | 20101115 |
Package NDC: | 68012-258-21 |
Package Description: | 21 TABLET in 1 BOTTLE (68012-258-21) |
NDC Code | 68012-258-21 |
Proprietary Name | CYCLOSET |
Package Description | 21 TABLET in 1 BOTTLE (68012-258-21) |
Product NDC | 68012-258 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | bromocriptine mesylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20101115 |
Marketing Category Name | NDA |
Labeler Name | Santarus, Inc. |
Substance Name | BROMOCRIPTINE MESYLATE |
Strength Number | .8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |